Hypertransmission and Vision in Aging and Age-Related Macular Degeneration: Longitudinal Data From ALSTAR2 - 18/11/25
, Lukas Goerdt a, cHighlights |
• | Novel review software for SD-OCTA allows for reliable HT assessment. |
• | Hypertransmission is most frequent in intermediate- followed by early AMD and normals. |
• | LHyperTD are generally rare in the ALSTAR2 dataset. |
• | Visual function impairment relates to AMD stage rather than LHyperTD presence. |
Résumé |
Purpose |
To investigate the presence of hypertransmission (HT) in normal aging, early (e)AMD, and intermediate (i)AMD, changes over 3 years, and the impact of HTs ≥ 250 µm (LHyperTD) on 7 tests of scotopic, mesopic, and photopic vision.
Design |
Prospective cohort study.
Subjects |
Participants of the Alabama Study on Early Age-Related Macular Degeneration 2.
Methods |
ALSTAR2 participants underwent spectral domain optical coherence tomography angiography (OCTA), color fundus photography, and vision testing at baseline and 3-year follow-up. HT presence and stepped diameters in choroidal en face slabs were assessed with custom review software. Only LHyperTD were analyzed at follow-up. AMD was staged via AREDS 9-step. Vision at baseline and follow-up between eyes with and without LHyperTD was analyzed with linear regression.
Main outcome measures |
Presence, size, and illustrative examples of HT, association with tests of photopic, mesopic and scotopic vision.
Results |
Baseline data was available on 460 eyes of 460 patients (mean age 71.5 ± 5.7 years, 277 female; 236 normal, 134 eAMD, 90 iAMD). HT of any size were found in iAMD (86.7%), eAMD (35.1%), and normal (3.8%) eyes, with proportional LHyperTD (13.3% vs 4.2% vs 0.4%, P < .01). For 339 eyes (mean age 71.2 ± 5.8 years, 206 female, 181 normal, 92 eAMD, 66 iAMD), LHyperTD presence significantly increased in normal ( P = .01) and iAMD ( P < .01) but not in eAMD eyes. At baseline, photopic contrast sensitivity (CS), mesopic CS, and rod intercept time (for rod mediated dark adaptation, RMDA) were worse in eyes with LHyperTD compared to eyes without (all P < .01). At follow-up, the same were worse in LHyperTD (all P < .01), as well as low luminance visual acuity ( P < .01) and scotopic light sensitivity ( P = .05).
Conclusion |
LHyperTD are rare in normal and eAMD eyes and associate with mesopic and scotopic visual functions in addition to risk-indicating RMDA. Delayed RMDA reflects other factors other than LHyperTD including differences in disease stage. Our analysis of HT < 250 µm may inform other studies of early disease. LHyperTD are best utilized as imaging biomarkers for later stages of iAMD than ALSTAR2.
Le texte complet de cet article est disponible en PDF.Abbreviations : ALSTAR2, AMD, AREDS, BCVA, CFP, cRORA, CS, dB, eAMD, ELM, EZ, HT, iAMD, iRORA, LLVA, LHyperTD, LS, OCT, RIT, RMDA, RPE, SDD, SDOCT, SDOCTA
Plan
Vol 280
P. 399-413 - décembre 2025 Retour au numéro
Article précédent
- Does Retinal Artery Occlusion Increase the Risk of Following Acute Coronary Syndrome and All-cause Mortality? A Systematic Review and Meta-Analysis
- ERFAN HASHEMI, FRANCISCO J. BONILLA-ESCOBAR, HOMA MAZAHERINIA, MEHDI AZIZMOHAMMAD LOOHA, DANIEL SÁNCHEZ-CANO, J. FERNANDO AREVALO
- Intraocular Pressure and Ocular Perfusion Pressure in Central Serous Chorioretinopathy
- Felice Cardillo Piccolino, Alessandro Arrigo, Paolo Forte, Lorenzo Mangoni, Jennifer Cattaneo, Daniela Fruttini, Francesco Bandello, Massimo Nicolò, Chiara Maria Eandi, Marco Lupidi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?